Articoli scientifici
- The psychological impact of quarantine and how to reduce it: rapid review of the evidence. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30460-8/fulltext
- COVID-19 Mental Health Impacts: Resources for Psychiatrists https://www.psychiatry.org/news-room/apa-blogs/apa-blog/2020/03/covid-19-mental-health-impacts-resources-for-psychiatrist
- COVID-19: Potential Implications for Individuals with Substance Use Disorders https://www.drugabuse.gov/about-nida/noras-blog/2020/03/covid-19-potential-implications-individuals-substance-use-disorders
- Coronavirus Covid_19 https://www.nejm.org/coronavirus?cid=DM88311&bid=165326853
- COVID-19 Guidance for People Who Use Drugs and Harm Reduction Programs https://harmreduction.org/miscellaneous/covid-19-guidance-for-people-who-use-drugs-and-harm-reduction-programs/
- Istruzioni operative Società di Epidemiologia Psichiatrica https://siep.it/presentazione-delle-istruzioni-operative-siep/
- INDICAZIONI AD INTERIM
PER UN UTILIZZO RAZIONALE DELLE PROTEZIONI PER INFEZIONE DA SARS-COV-2 NELLE ATTIVITÀ SANITARIE E SOCIOSANITARIE (ASSISTENZA A SOGGETTI AFFETTI DA COVID-19) NELL’ATTUALE SCENARIO EMERGENZIALE SARS-COV-2
Gruppo di Lavoro ISS Prevenzione e Controllo delle Infezioni https://www.fnopi.it/wp-content/uploads/2020/03/rapporto-covid-19-2-2020.pdf - Covid-19: nei fumatori il rischio di finire in terapia intensiva è più del doppio https://ofad.iss.it/2020/03/12/covid-19-nei-fumatori-il-rischio-di-finire-in-terapia-intensiva-e-piu-del-doppio/
- Riduzione del danno da COVID-19 per le persone che usano droghe https://www.talkingdrugs.org/it/riduzione-del-danno-da-covid-19-per-le-persone-che-usano-droghe
- Linee di indirizzo per la gestione dell’infrazione da coronavirus nelle sedi delle comunità terapeutiche del territorio della ULSS 3 Veneto Linee CT Venezia
- .Disposizioni DSMDP Forlì Disposizioni DSMDP Covid 19
- Information from the Norwegian Centre for Addiction Research (SERAF), University of Oslo, Norway, about special measures for vulnerable groups with substance use disorders (SUD) during the Coronavirus epidemic https://www.med.uio.no/klinmed/english/research/centres/seraf/news-and-events/news/2020/information-seraf-coronavirus.html
- Pandemia da coronavirus, impatto sulla salute mentale https://siep.it/pandemia-da-coronavirus-impatto-sulla-salute-mentale/
- SIMIT Società Italiana di Malattie Infettive e Tropicali – Vademecum per la cura Covid-19 http://www.simit.org/medias/1569-covid19-vademecum-13-03-202.pdf con allegati http://www.simit.org/medias/1571-allegati-vademecum.zip
- Resoconto prassi operative SerDP Reggio Emilia RESOCONTO REGGIO EMILIA PER SITD
- First ISAM webinar on Covid-19 and drug addiction, 23-3-2020 (in buona sostanza un convegno online, in inglese con sottotitoli) https://youtu.be/XROBO0YD-HQ
- SIP Società Italiana di Psichiatria – raccomandazioni Covid-19 – Raccomandazioni COVID 19
- ASAM American Society of Addiction Medicine – Covid-19 resources https://www.asam.org/Quality-Science/covid-19-coronavirus
- Nora Volkow – Collision of the COVID-19 and Addiction Epidemics – https://annals.org/aim/fullarticle/2764313/collision-covid-19-addiction-epidemics
- John Marsden et al – Mitigating and learning from the impact of COVID‐19 infection on addictive disorders https://onlinelibrary.wiley.com/doi/epdf/10.1111/add.15080
- Istituto Superiore di Sanità – Dipendenze e Covid-19 https://www.epicentro.iss.it/coronavirus/sars-cov-2-dipendenze
- UNODC – Suggestions about treatment, care and rehabilitation of people with drug use disorder in the context of the COVID-19 pandemic https://www.unodc.org/ropan/en/suggestions-about-treatment–care-and-rehabilitation-of-people-with-drug-use-disorder-in-the-context-of-the-covid-19-pandemic.html (cliccarein fondo per aprire l’infografica)
- EMCDDA trendspotter briefing – Impact of COVID-19 on drug services and help-seeking in Europe https://www.emcdda.europa.eu/publications/ad-hoc/impact-of-covid-19-on-drug-services-and-help-seeking-in-europe
- COVID-19 and Substance Use Disorders: Recommendations to a Comprehensive Healthcare Response. An International Society of Addiction Medicine Practice and Policy Interest Group Position Paper (Farhoudian et al.) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7368103/